Zentek Announces CEO Transition

Zentek Ltd., an intellectual property technology company, has disclosed that Greg Fenton's consulting contract as Chief Executive Officer will not be renewed when it expires on March 31, 2026. The board of directors has started the search for a new CEO, while the current executive team will maintain leadership in the interim.

Eric Wallman, Chairman of Zentek's board, expressed gratitude to Fenton for his leadership in growth and diversification over the past seven years. The board aims to appoint a successor who will lead Zentek from research and development to commercialization.

Zentek, known for its ZenGUARD™ technology, enhances bacterial and viral filtration in masks and aims to replicate this with HVAC filters. The company, in partnership with McMaster University, is also developing solutions for diagnostic and therapeutic markets through its subsidiary, Triera Biosciences Ltd.